Does SECUKINUMAB Cause Nasopharyngitis? 7,022 Reports in FDA Database

Q: Does SECUKINUMAB cause Nasopharyngitis?

7,022 reports of Nasopharyngitis have been filed with the FDA for SECUKINUMAB, representing 4.6% of all SECUKINUMAB adverse event reports.

Q: How dangerous is Nasopharyngitis from SECUKINUMAB?

Of 7,022 reports, 1,438 (20.5%) resulted in death and 2,092 required hospitalization.

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 7,022 reports of Nasopharyngitis have been filed in association with SECUKINUMAB (COSENTYX). This represents 4.6% of all adverse event reports for SECUKINUMAB.

7,022

Reports of Nasopharyngitis with SECUKINUMAB

4.6%

of all SECUKINUMAB reports

1,438

Deaths

2,092

Hospitalizations

How Dangerous Is Nasopharyngitis From SECUKINUMAB?

Of the 7,022 reports, 1,438 (20.5%) resulted in death, 2,092 (29.8%) required hospitalization, and 1,790 (25.5%) were considered life-threatening.